Related Experiment Video
Updated: Jun 27, 2026
13:04
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end
Katharina A Sterenczak1, Saskia Willenbrock, Matthias Barann
1Small Animal Clinic and Research Cluster of Excellence REBIRTH, University of Veterinary Medicine, Bischofsholer Damm 15, D-30173 Hannover, Germany.
Gene
|December 9, 2008
Summary
Researchers identified novel RAGE splicing variants in canine and human tissues, offering insights into receptor regulation and potential roles in cancer. This study advances understanding of RAGE
Area of Science:
- Molecular biology
- Cancer research
- Immunology
Background:
- Receptor for Advanced Glycation Endproducts (RAGE) is implicated in various diseases, including cancer.
- RAGE splicing variants are known regulatory mechanisms, but their role in tumors is understudied.
- Soluble RAGE (sRAGE) deregulation is linked to diseases like Alzheimer's and diabetes.
Purpose of the Study:
- To screen canine and human tumors, healthy tissues, and cell lines for RAGE splicing variants.
- To analyze the structure and characteristics of identified RAGE variants.
- To investigate the ratio of major RAGE transcript variants in different tissues.
Main Methods:
- Screening of tumor and healthy tissues, and cancer cell lines for RAGE splicing variants.
- Structural analysis of identified RAGE variants.
- Quantitative Real-Time PCR to analyze transcript variant ratios.
Main Results:
- Characterized 24 novel canine and 4 novel human RAGE splicing variants.
- Analyzed the structure, characteristics, and derived protein forms of these variants.
- Observed that healthy and neoplastic tissues predominantly express full-length RAGE transcripts and variants with intron 1 insertions.
Conclusions:
- Identified numerous new RAGE splicing variants, expanding the known repertoire.
- Provided structural classification and protein derivations for these novel variants.
- Highlighted potential differences in RAGE transcript expression between healthy and cancerous tissues.
